Literature DB >> 24882693

Molecular conformation of the full-length tumor suppressor NF2/Merlin--a small-angle neutron scattering study.

Jahan Ali Khajeh1, Jeong Ho Ju1, Moussoubaou Atchiba1, Marc Allaire2, Christopher Stanley3, William T Heller3, David J E Callaway1, Zimei Bu4.   

Abstract

The tumor suppressor protein Merlin inhibits cell proliferation upon establishing cell-cell contacts. Because Merlin has high level of sequence similarity to the Ezrin-Radixin-Moesin family of proteins, the structural model of Ezrin-Radixin-Moesin protein autoinhibition and cycling between closed/resting and open/active conformational states is often employed to explain Merlin function. However, recent biochemical studies suggest alternative molecular models of Merlin function. Here, we have determined the low-resolution molecular structure and binding activity of Merlin and a Merlin(S518D) mutant that mimics the inactivating phosphorylation at S518 using small-angle neutron scattering and binding experiments. Small-angle neutron scattering shows that, in solution, both Merlin and Merlin(S518D) adopt a closed conformation, but binding experiments indicate that a significant fraction of either Merlin or Merlin(S518D) is capable of binding to the target protein NHERF1. Upon binding to the phosphatidylinositol 4,5-bisphosphate lipid, the wild-type Merlin adopts a more open conformation than in solution, but Merlin(S518D) remains in a closed conformation. This study supports a rheostat model of Merlin in NHERF1 binding and contributes to resolving a controversy about the molecular conformation and binding activity of Merlin.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Ezrin; Merlin; neurofibromatosis type 2; phosphatidylinositol 4,5-bisphosphate; small-angle neutron scattering

Mesh:

Substances:

Year:  2014        PMID: 24882693      PMCID: PMC4407695          DOI: 10.1016/j.jmb.2014.05.011

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  60 in total

1.  Structural basis for neurofibromatosis type 2. Crystal structure of the merlin FERM domain.

Authors:  Toshiyuki Shimizu; Azusa Seto; Nobuo Maita; Keisuke Hamada; Shoichiro Tsukita; Sachiko Tsukita; Toshio Hakoshima
Journal:  J Biol Chem       Date:  2001-12-27       Impact factor: 5.157

2.  p21-activated kinase links Rac/Cdc42 signaling to merlin.

Authors:  Guang-Hui Xiao; Alexander Beeser; Jonathan Chernoff; Joseph R Testa
Journal:  J Biol Chem       Date:  2001-11-21       Impact factor: 5.157

3.  The NF2 tumor suppressor gene product, merlin, mediates contact inhibition of growth through interactions with CD44.

Authors:  H Morrison; L S Sherman; J Legg; F Banine; C Isacke; C A Haipek; D H Gutmann; H Ponta; P Herrlich
Journal:  Genes Dev       Date:  2001-04-15       Impact factor: 11.361

Review 4.  PIP(2) and proteins: interactions, organization, and information flow.

Authors:  Stuart McLaughlin; Jiyao Wang; Alok Gambhir; Diana Murray
Journal:  Annu Rev Biophys Biomol Struct       Date:  2001-10-25

5.  Merlin phosphorylation by p21-activated kinase 2 and effects of phosphorylation on merlin localization.

Authors:  Joseph L Kissil; Kristen C Johnson; Matthew S Eckman; Tyler Jacks
Journal:  J Biol Chem       Date:  2002-01-08       Impact factor: 5.157

6.  The structure of the FERM domain of merlin, the neurofibromatosis type 2 gene product.

Authors:  Beom Sik Kang; David R Cooper; Yancho Devedjiev; Urszula Derewenda; Zygmunt S Derewenda
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2002-02-21

7.  The Nf2 tumor suppressor, merlin, functions in Rac-dependent signaling.

Authors:  R J Shaw; J G Paez; M Curto; A Yaktine; W M Pruitt; I Saotome; J P O'Bryan; V Gupta; N Ratner; C J Der; T Jacks; A I McClatchey
Journal:  Dev Cell       Date:  2001-07       Impact factor: 12.270

8.  Effect of merlin phosphorylation on neurofibromatosis 2 (NF2) gene function.

Authors:  Ezequiel I Surace; Carrie A Haipek; David H Gutmann
Journal:  Oncogene       Date:  2004-01-15       Impact factor: 9.867

9.  Mutagenesis of the phosphatidylinositol 4,5-bisphosphate (PIP(2)) binding site in the NH(2)-terminal domain of ezrin correlates with its altered cellular distribution.

Authors:  C Barret; C Roy; P Montcourrier; P Mangeat; V Niggli
Journal:  J Cell Biol       Date:  2000-11-27       Impact factor: 10.539

10.  Phosphoinositide binding and phosphorylation act sequentially in the activation mechanism of ezrin.

Authors:  Bruno T Fievet; Alexis Gautreau; Christian Roy; Laurence Del Maestro; Paul Mangeat; Daniel Louvard; Monique Arpin
Journal:  J Cell Biol       Date:  2004-03-01       Impact factor: 10.539

View more
  9 in total

1.  α-Catenin Structure and Nanoscale Dynamics in Solution and in Complex with F-Actin.

Authors:  Iain D Nicholl; Tsutomu Matsui; Thomas M Weiss; Christopher B Stanley; William T Heller; Anne Martel; Bela Farago; David J E Callaway; Zimei Bu
Journal:  Biophys J       Date:  2018-07-11       Impact factor: 4.033

2.  Controllable Activation of Nanoscale Dynamics in a Disordered Protein Alters Binding Kinetics.

Authors:  David J E Callaway; Tsutomu Matsui; Thomas Weiss; Laura R Stingaciu; Christopher B Stanley; William T Heller; Zimei Bu
Journal:  J Mol Biol       Date:  2017-03-08       Impact factor: 5.469

3.  Parathyroid hormone initiates dynamic NHERF1 phosphorylation cycling and conformational changes that regulate NPT2A-dependent phosphate transport.

Authors:  Qiangmin Zhang; Kunhong Xiao; José M Paredes; Tatyana Mamonova; W Bruce Sneddon; Hongda Liu; Dawei Wang; Sheng Li; Jennifer C McGarvey; David Uehling; Rima Al-Awar; Babu Joseph; Frederic Jean-Alphonse; Angel Orte; Peter A Friedman
Journal:  J Biol Chem       Date:  2019-01-29       Impact factor: 5.157

4.  Phosphatidylinositol 4,5-bisphosphate clusters the cell adhesion molecule CD44 and assembles a specific CD44-Ezrin heterocomplex, as revealed by small angle neutron scattering.

Authors:  Xiaodong Chen; Jahan Ali Khajeh; Jeong Ho Ju; Yogesh K Gupta; Christopher B Stanley; Changwoo Do; William T Heller; Aneel K Aggarwal; David J E Callaway; Zimei Bu
Journal:  J Biol Chem       Date:  2015-01-08       Impact factor: 5.157

Review 5.  Self-Sustained Regulation or Self-Perpetuating Dysregulation: ROS-dependent HIF-YAP-Notch Signaling as a Double-Edged Sword on Stem Cell Physiology and Tumorigenesis.

Authors:  Chin-Lin Guo
Journal:  Front Cell Dev Biol       Date:  2022-06-14

6.  Angiomotin binding-induced activation of Merlin/NF2 in the Hippo pathway.

Authors:  Youjun Li; Hao Zhou; Fengzhi Li; Siew Wee Chan; Zhijie Lin; Zhiyi Wei; Zhou Yang; Fusheng Guo; Chun Jye Lim; Wancai Xing; Yuequan Shen; Wanjin Hong; Jiafu Long; Mingjie Zhang
Journal:  Cell Res       Date:  2015-06-05       Impact factor: 25.617

Review 7.  Role of Merlin/NF2 inactivation in tumor biology.

Authors:  A M Petrilli; C Fernández-Valle
Journal:  Oncogene       Date:  2015-04-20       Impact factor: 9.867

8.  Lipid binding promotes the open conformation and tumor-suppressive activity of neurofibromin 2.

Authors:  Krishna Chinthalapudi; Vinay Mandati; Jie Zheng; Andrew J Sharff; Gerard Bricogne; Patrick R Griffin; Joseph Kissil; Tina Izard
Journal:  Nat Commun       Date:  2018-04-06       Impact factor: 14.919

9.  NEDD4L-mediated Merlin ubiquitination facilitates Hippo pathway activation.

Authors:  Yiju Wei; Patricia P Yee; Zhijun Liu; Lei Zhang; Hui Guo; Haiyan Zheng; Benjamin Anderson; Melissa Gulley; Wei Li
Journal:  EMBO Rep       Date:  2020-10-14       Impact factor: 9.071

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.